1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award is sponsored by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP).
This award supports the translation of promising preclinical findings into products for clinical applications (prevention, detection, diagnosis, treatment, or quality of life) for diseases or conditions related to the FY26 PRMRP topic areas and strategic goals. Products can be tangible items or knowledge products.
The program expects research to take an established proof-of-concept or prototype through final preclinical development, aiming for regulatory filing or translation into clinical practice. Products should also address the healthcare needs of military Service Members, Veterans, and their Families.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Independent investigators affiliated with an eligible organization are eligible to be named PI. Each investigator may be named on only one FY26 PRMRP application as a PI. Confirm the full requirements in the official notice before applying.
The published deadline was August 6, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award is funded by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Glioblastoma Research Program (GBMRP) is sponsored by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). The Glioblastoma Research Program (GBMRP) is a stand-alone program created in FY24 to fund high-impact research specifically for glioblastoma, the most common and aggressive type of brain cancer. The CDMRP uses a community-driven process to identify and fund high-impact research.
Tick-Borne Disease Research Program -- Therapeutic/Diagnostic Research Award is sponsored by Department of Defense (DOD) / Congressionally Directed Medical Research Programs (CDMRP). This award supports product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Individuals in a mentored position are not considered independent investigators.
DoD Multidisciplinary Research Program of the University Research Initiative (MURI) is sponsored by Department of Defense (DoD) - Office of Naval Research (ONR). The Multidisciplinary Research Program of the University Research Initiative (MURI), administered by the Department of Defense Office of Naval Research, supports basic research in science and engineering at U. S.
SBIR SF254-D1206: Knowledge-Guided Test and Evaluation Frameworks for proliferated Low Earth Orbit Constellations is sponsored by U.S. Air Force. DOD SBIR topic SF254-D1206: Knowledge-Guided Test and Evaluation Frameworks for proliferated Low Earth Orbit Constellations. Component: U.S. Air Force. Command: SDA. Solicitation: DoD SBIR 2025.4. Phase(s): D2PII, II, SPII. Status: Pre-Release. Open date: 3/4/2026.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article